Drug name - Nexiclon Xr

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8337890 ATHENA Modified release formulations containing drug-ion exchange resin complexes Apr, 2027

(4 years from now)

US8623409 ATHENA Clonidine formulation Sep, 2031

(8 years from now)

Drugs and Companies using CLONIDINE ingredient

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 0.17MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription
EQ 0.26MG BASE TABLET, EXTENDED RELEASE;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.